Precigen (PGEN) Cost of Revenue (2016 - 2025)

Precigen (PGEN) has disclosed Cost of Revenue for 12 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue rose 36.53% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.8 million through Dec 2025, up 13.03% year-over-year, with the annual reading at $4.8 million for FY2025, 13.03% up from the prior year.
  • Cost of Revenue for Q4 2025 was $1.6 million at Precigen, up from $1.0 million in the prior quarter.
  • The five-year high for Cost of Revenue was $7.4 million in Q1 2021, with the low at $482000.0 in Q3 2021.
  • Average Cost of Revenue over 5 years is $1.7 million, with a median of $1.3 million recorded in 2022.
  • The sharpest move saw Cost of Revenue plummeted 93.39% in 2021, then soared 227.18% in 2022.
  • Over 5 years, Cost of Revenue stood at $2.9 million in 2021, then tumbled by 56.46% to $1.3 million in 2022, then rose by 8.04% to $1.4 million in 2023, then dropped by 13.92% to $1.2 million in 2024, then soared by 36.53% to $1.6 million in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $1.6 million, $1.0 million, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.